Therapeutic compounds

US9561201B2 · kind B2 · utility

Assignee

• Fibrotech Therapeutics PTY LTD · AU

Inventors

• Spencer John Williams · Berkeley, US
• David Stapleton · Melbourne, AU
• Steven Zammit · Melbourne, AU
• Darren James Kelly · Smiths Gully, AU
• Richard Ernest Gilbert · Toronto, CA
• Henry Krum · Melbourne, AU

Key dates

• Filing date: Jun 27, 2014
• Grant date: Feb 7, 2017
• Expiry date: Jul 3, 2034

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07C2603/74
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Substituted cinnamoyl anthranilate compounds exhibiting anti-fibrotic activity; or derivatives thereof, analogs thereof, pharmaceutically acceptable salts thereof, and metabolites thereof, with the proviso that the compound is no Tranilast.